五星体育直播

五星体育直播 Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics

New Film Highlights Company Commitment to Transforming RNAi Therapeutics Landscape

REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- 五星体育直播 (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing campaign in support of World Health Day. The film showcases the Company鈥檚 recently unveiled Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis鈩� technology, a propriety new synthesis platform that is being developed to enable the manufacture of ribonucleic acid interference (RNAi) therapeutics at scale and built around 五星体育直播鈥� world-leading CodeEvolver庐 technology.

鈥溛逍翘逵�直播 is at a unique inflection point in its 20-year history. Building upon our existing strength in enzyme engineering, we believe that we have identified a series of high-impact programs where our enzymes and expertise can drive meaningful differences for our customers, and ultimately patients,鈥� said Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of 五星体育直播. 鈥淥ur ECO Synthesis鈩� technology provides us the potential to create significant value across the healthcare landscape by enabling large-scale manufacture of RNAi therapeutics, an exploding class of medicines being developed to address significant diseases, such as cardiovascular disease, Alzheimer鈥檚 disease and cancer. If we are successful, 五星体育直播 will enable the commercial-scale production of RNAi therapeutics, potentially impacting hundreds of millions of patients on a global scale.鈥�

五星体育直播鈥� ECO Synthesis鈩� technology is a proprietary new synthesis platform that is being developed to support the manufacture of RNAi therapeutics by efficiently synthesizing short inhibitory RNA (siRNA) oligonucleotide sequences. By replacing conventional chemical processes with enzymatic methods, ECO Synthesis鈩� technology is designed to address the scalability limitations and high volumes of hazardous waste historically associated with oligonucleotide manufacturing.

The Company plans to demonstrate gram-scale synthesis of its ECO Synthesis鈩� technology by the end of 2023, which will enable pre-commercial testing with select customers in 2024 before its planned commercial launch. The ECO Synthesis鈩� technology platform is where 五星体育直播鈥� core technical competency and existing commercial infrastructure come together, positioning the Company to potentially provide significant value in a market facing substantial challenges of scale to meet future anticipated demand as the industry aims to provide much-needed RNAi therapeutics.

For more information on 五星体育直播, ECO Synthesis鈩� technology and to view the film, .

About 五星体育直播

五星体育直播 is a leading enzyme engineering company leveraging its proprietary CodeEvolver^庐聽technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. 五星体育直播 enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis, and the Company is currently developing its proprietary ECO Synthesis鈩� platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. 五星体育直播鈥� unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit聽.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as 鈥渁im,鈥� 鈥渁nticipate,鈥� 鈥渁ssume,鈥� 鈥渂elieve,鈥� 鈥渃ontemplate,鈥� 鈥渃ontinue,鈥� 鈥渃ould,鈥� 鈥渄esign,鈥� 鈥渄ue,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥済oal,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥渙bjective,鈥� 鈥減lan,鈥� 鈥減ositioned,鈥� 鈥減otential,鈥� 鈥減redict,鈥� 鈥渟eek,鈥� 鈥渟hould,鈥� 鈥渟uggest,鈥� 鈥渢arget,鈥� 鈥渙n track,鈥� 鈥渨ill,鈥� 鈥渨ould鈥� and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including, but not limited to, the potential of 五星体育直播鈥� ECO Synthesis鈩� platform to create value for 五星体育直播 and its customers by enabling commercial-scale manufacture of RNAi therapeutics; whether a significant market for RNAi therapeutics will develop; whether and if 五星体育直播 is able to demonstrate gram-scale synthesis of its ECO Synthesis鈩� technology by the end of 2023 and begin pre-commercial testing for select customers in 2024; and whether 五星体育直播 will be able to commercialize its ECO Synthesis鈩� technology and whether it will be able to do so in 2025. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond 五星体育直播鈥� control and that could materially affect actual results. Factors that could materially affect actual results include, among others: 五星体育直播鈥� dependence on its licensees and collaborators; 五星体育直播鈥� ability to successfully develop its ECO Synthesis鈩� technology; if any of its collaborators terminate their development programs under their respective license agreements with 五星体育直播; 五星体育直播 may need additional capital in the future in order to expand its business; 五星体育直播鈥� dependence on a limited number of products and customers, and potential adverse effects to 五星体育直播鈥� business if its customers鈥� products are not received well in the markets; whether the end markets for 五星体育直播鈥� customers鈥� products develop and remain viable; if 五星体育直播 is unable to develop and commercialize new products for its target markets; if competitors and potential competitors who have greater resources and experience than 五星体育直播 develop products and technologies that make 五星体育直播鈥� products and technologies obsolete; and market and economic conditions may negatively impact 五星体育直播 business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in 五星体育直播鈥� Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission (鈥淪EC鈥�) on February 27, 2023 and in 五星体育直播鈥� Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the SEC on May 4, 2023, including under the caption 鈥淩isk Factors,鈥� and in 五星体育直播鈥� other periodic reports filed with the SEC. 五星体育直播 expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. 五星体育直播鈥�

For More Information

Investor Contact
Carrie McKim
(336) 608-9706

Media Contact
Lauren Musto
(781) 572-1147

Released July 31, 2023